The design, synthesis and evaluation of hypoxia-activated pro-oligonucleotides

被引：23
|
作者：
Zhang, Nan [1 ,2 ]
Tan, Chunyan [1 ]
Cai, Puqin [1 ]
Zhang, Peizhuo [3 ]
Zhao, Yufen [2 ]
Jiang, Yuyang [1 ,4 ]
机构：
[1] Tsinghua Univ, Grad Sch Shenzhen, Key Lab Chem Biol, Shenzhen 518055, Guangdong, Peoples R China
[2] Tsinghua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China
[3] Shanghai GenePharma Co Ltd, Shanghai 201203, Peoples R China
[4] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China
来源：
CHEMICAL COMMUNICATIONS | 2009年 / 22期
关键词：
PRODRUGS;
D O I：
10.1039/b903331a
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hypoxia-activated pro-oligonucleotides were synthesized through the commercial phosphoramidite method, and could be readily cleaved to form normal oligos with good hypoxia selectivity in vitro under the effect of reductases, as well as in tumor cell extract.
引用
收藏
页码：3216 / 3218
页数：3
相关论文
共 50 条
  • [11] Exploring chronic and transient tumor hypoxia for predicting the efficacy of hypoxia-activated pro-drugs
    Mathur, Shreya
    Chen, Shannon
    Rejniak, Katarzyna A.
    NPJ SYSTEMS BIOLOGY AND APPLICATIONS, 2024, 10 (01)
  • [12] Exploring chronic and transient tumor hypoxia for predicting the efficacy of hypoxia-activated pro-drugs
    Shreya Mathur
    Shannon Chen
    Katarzyna A. Rejniak
    npj Systems Biology and Applications, 10
  • [13] A hypoxia-activated antibacterial prodrug
    Yeoh, Yuan Qi
    Horsley, John R.
    Polyak, Steven W.
    Abell, Andrew D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (11)
  • [14] Hypoxia-activated anticancer drugs
    Denny, WA
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (06) : 635 - 646
  • [15] Uptake and quantification of intracellular concentration of lipophilic pro-oligonucleotides in HeLa cells
    Bologna, JC
    Vivès, E
    Imbach, JL
    Morvan, F
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2002, 12 (01): : 33 - 41
  • [16] Targeting Tumor Hypoxia With Hypoxia-Activated Prodrugs
    Yeh, Jen Jen
    Kim, William Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) : 1505 - 1508
  • [17] Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands
    Cheng, Weiyan
    Li, Shasha
    Han, Siyuan
    Miao, Ruoyang
    Wang, Suhua
    Liu, Chunxia
    Wei, Han
    Tian, Xin
    Zhang, Xiaojian
    BIOORGANIC & MEDICINAL CHEMISTRY, 2023, 82
  • [18] Hypoxia-Activated Prodrug Derivatives of Carbonic Anhydrase Inhibitors in Benzenesulfonamide Series: Synthesis and Biological Evaluation
    Anduran, Emilie
    Aspatwar, Ashok
    Parvathaneni, Nanda-Kumar
    Suylen, Dennis
    Bua, Silvia
    Nocentini, Alessio
    Parkkila, Seppo
    Supuran, Claudiu T.
    Dubois, Ludwig
    Lambin, Philippe
    Winum, Jean-Yves
    MOLECULES, 2020, 25 (10):
  • [19] Design of optimized hypoxia-activated prodrugs using pharmacokinetic/pharmacodynamic modeling
    Foehrenbacher, Annika
    Secomb, Timothy W.
    Wilson, William R.
    Hicks, Kevin O.
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [20] Evaluation of a novel hypoxia-activated prodrug strategy in colorectal cancer cells
    Hussain, Omar
    Johansson, Henrik
    Allison, Simon J.
    Pedersen, Daniel S.
    Phillips, Roger M.
    CANCER RESEARCH, 2018, 78 (13)
12345